KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Non-cash Items: 2012-2025

Historic Non-cash Items for Rigel Pharmaceuticals (RIGL) over the last 14 years, with Sep 2025 value amounting to $17.3 million.

  • Rigel Pharmaceuticals' Non-cash Items rose 44.17% to $17.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.3 million, marking a year-over-year increase of 44.17%. This contributed to the annual value of $10.6 million for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, Rigel Pharmaceuticals' Non-cash Items stood at $17.3 million, which was down 15.61% from $20.5 million recorded in Q2 2025.
  • Rigel Pharmaceuticals' 5-year Non-cash Items high stood at $23.2 million for Q1 2025, and its period low was $1.6 million during Q4 2022.
  • Over the past 3 years, Rigel Pharmaceuticals' median Non-cash Items value was $14.6 million (recorded in 2023), while the average stood at $15.3 million.
  • In the last 5 years, Rigel Pharmaceuticals' Non-cash Items tumbled by 76.44% in 2022 and then skyrocketed by 560.44% in 2023.
  • Over the past 5 years, Rigel Pharmaceuticals' Non-cash Items (Quarterly) stood at $6.8 million in 2021, then crashed by 76.44% to $1.6 million in 2022, then skyrocketed by 560.44% to $10.6 million in 2023, then remained steady at $10.6 million in 2024, then soared by 44.17% to $17.3 million in 2025.
  • Its Non-cash Items was $17.3 million in Q3 2025, compared to $20.5 million in Q2 2025 and $23.2 million in Q1 2025.